You have 9 free searches left this month | for more free features.

thalidomide

Showing 26 - 50 of 271

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Tumors Metastatic to Brain Trial in Philadelphia (radiation, drug, procedure)

Completed
  • Tumors Metastatic to Brain
  • radiation therapy
  • +2 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

HIV, Stomatitis, Aphthous Trial in Puerto Rico, United States (Thalidomide)

Completed
  • HIV Infections
  • Stomatitis, Aphthous
  • Thalidomide
  • Birmingham, Alabama
  • +39 more
Oct 27, 2021

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)

Recruiting
  • Glioma
  • +6 more
  • Metronomic Cyclophosphamide
  • Thalidomide
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 22, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Multiple Myeloma Trial in Austria, Germany (Carfilzomib, Thalidomide, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Graz, Austria
  • +20 more
Jan 18, 2022

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Immunoglobulin Light-Chain Amyloidosis Trial in Guangzhou (Thalidomide, Cyclophosphamide)

Recruiting
  • Immunoglobulin Light-Chain Amyloidosis
  • Guangzhou, Guangdong, China
    Guangdong Provincial People'S Hospital
Oct 27, 2020

Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)

Terminated
  • Melanoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Sep 1, 2020

Crohn Disease Trial in Italy (Thalidomide, Infliximab)

Terminated
  • Crohn Disease
  • Napoli, Campania, Italy
  • +5 more
Sep 2, 2020

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • ascorbic acid
  • +3 more
  • Cleveland, Ohio
  • +1 more
Jul 23, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in Canada (prednisone, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Calgary, Alberta, Canada
  • +17 more
Sep 11, 2020

Plasma Cell Myeloma Trial in Israel, United States (Laboratory Biomarker Analysis, Lenalidomide, Melphalan)

Active, not recruiting
  • Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +5 more
  • Mobile, Alabama
  • +392 more
Jan 25, 2023

COVID-19 Thalidomide Trial (, Thalidomide)

Unknown status
  • COVID-19 Thalidomide
  • placebo
  • Thalidomide
  • (no location specified)
Feb 19, 2020

COVID-19 Thalidomide Trial (thalidomide, )

Unknown status
  • COVID-19 Thalidomide
  • thalidomide
  • placebo
  • (no location specified)
Feb 19, 2020

Diffuse Large B-cell Lymphoma Trial in ZhengZhou (Chidamide, Vinorelbine, Liposomal Doxorubicin or mitoxantrone)

Unknown status
  • Diffuse Large B-cell Lymphoma
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 31, 2020

Multiple Myeloma Trial in Singapore (Bortezomib, Cyclophosphamide, Dexamethasone)

Unknown status
  • Multiple Myeloma
  • Singapore, Singapore
    National University Hospital
Jan 23, 2020

Radiation Injuries Trial in Guangzhou, Guanzhou (Thalidomide)

Unknown status
  • Radiation Injuries
  • Thalidomide
  • Guangzhou, Guangdong, China
  • +2 more
Nov 21, 2019

Multiple Myeloma Trial in Brazil (Ixazomib, Thalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • Salvador, BA, Brazil
  • +5 more
Jan 10, 2020

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore, New York (oblimersen sodium, dexamethasone, thalidomide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • oblimersen sodium
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 15, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
  • Laboratory Biomarker Analysis
  • Thalidomide
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Thalidomide
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Multiple Myeloma Trial in Austria, Czechia, Germany (Ixazomib, Thalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Linz, Oberösterreich, Austria
  • +16 more
Dec 12, 2019

Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen

Completed
  • Fallopian Tube Cancer
  • +4 more
  • tamoxifen citrate
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021